These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10052684

  • 21. Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease.
    Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM.
    Microbes Infect; 2006 Aug; 8(9-10):2459-64. PubMed ID: 16963301
    [Abstract] [Full Text] [Related]

  • 22. Changes in autoantibodies against beta1-adrenoceptor and M2-muscarinic receptor during development of renovascular hypertension in rats.
    Zhi JM, Chen RF, Wu H, Liu HR, Zhao RR.
    Acta Biochim Biophys Sin (Shanghai); 2004 Dec; 36(12):793-7. PubMed ID: 15592645
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops.
    Wallukat G, Wollenberger A, Morwinski R, Pitschner HF.
    J Mol Cell Cardiol; 1995 Jan; 27(1):397-406. PubMed ID: 7539084
    [Abstract] [Full Text] [Related]

  • 25. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.
    Holthoff HP, Zeibig S, Jahns-Boivin V, Bauer J, Lohse MJ, Kääb S, Clauss S, Jahns R, Schlipp A, Münch G, Ungerer M.
    Circ Res; 2012 Aug 31; 111(6):675-84. PubMed ID: 22811559
    [Abstract] [Full Text] [Related]

  • 26. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.
    Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K, Ogawa S, Fu M.
    Eur Heart J; 2004 Jul 31; 25(13):1108-15. PubMed ID: 15231368
    [Abstract] [Full Text] [Related]

  • 27. Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects.
    Wallukat G, Fu HM, Matsui S, Hjalmarson A, Fu ML.
    Life Sci; 1999 Jul 31; 64(6-7):465-9. PubMed ID: 10069511
    [Abstract] [Full Text] [Related]

  • 28. Anti-peptide antibodies against an autoimmune epitope on human muscarinic receptor mimic functional autoantibodies against the same epitope in patients with idiopathic dilated cardiomyopathy.
    Fu ML.
    Eur Heart J; 1995 Dec 31; 16 Suppl O():89-91. PubMed ID: 8682112
    [Abstract] [Full Text] [Related]

  • 29. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
    Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R.
    Am Heart J; 2006 Oct 31; 152(4):697-704. PubMed ID: 16996841
    [Abstract] [Full Text] [Related]

  • 30. Characterization of anti-heart M2 muscarinic receptor antibodies--a combined clinical and experimental study.
    Fu ML.
    Mol Cell Biochem; 1996 Oct 31; 163-164():343-7. PubMed ID: 8974074
    [Abstract] [Full Text] [Related]

  • 31. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study.
    Deubner N, Berliner D, Schlipp A, Gelbrich G, Caforio AL, Felix SB, Fu M, Katus H, Angermann CE, Lohse MJ, Ertl G, Störk S, Jahns R, Etiology, Titre-Course, and Survival-Study Group.
    Eur J Heart Fail; 2010 Jul 31; 12(7):753-62. PubMed ID: 20494925
    [Abstract] [Full Text] [Related]

  • 32. β1-adrenergic and Muscarinic Acetylcholine Type 2 Receptor Antibodies are Increased in Graves' Hyperthyroidism and Decrease During Antithyroid Therapy.
    Tammelin K, Lundgren A, Holmberg M, Andersson B, Nyström HF.
    Exp Clin Endocrinol Diabetes; 2021 Nov 31; 129(11):783-790. PubMed ID: 33434937
    [Abstract] [Full Text] [Related]

  • 33. Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.
    Yalcin MU, Gurses KM, Kocyigit D, Kesikli SA, Ates AH, Evranos B, Yorgun H, Sahiner ML, Kaya EB, Oto MA, Guc D, Ozer N, Aytemir K.
    Clin Res Cardiol; 2015 Mar 31; 104(3):226-33. PubMed ID: 25351416
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Beneficial effect of muscarinic-2 antagonist on dilated cardiomyopathy induced by autoimmune mechanism against muscarinic-2 receptor.
    Matsui S, Fu ML, Hayase M, Katsuda S, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N.
    J Cardiovasc Pharmacol; 2001 Oct 31; 38 Suppl 1():S43-9. PubMed ID: 11811358
    [Abstract] [Full Text] [Related]

  • 38. Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism.
    Galloway A, Li H, Vanderlinde-Wood M, Khan M, Benbrook A, Liles C, Zillner C, Rao V, Cunningham MW, Yu X, Kem DC.
    Endocrine; 2015 Jun 31; 49(2):457-63. PubMed ID: 25500789
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.